Concord Biotech Limited Operating Cash Flow for the year ending March 31, 2024: USD 31.83 M

Concord Biotech Limited Operating Cash Flow is USD 31.83 M for the year ending March 31, 2024, a 6.33% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Concord Biotech Limited Operating Cash Flow for the year ending March 31, 2023 was USD 29.93 M, a 9.54% change year over year.
  • Concord Biotech Limited Operating Cash Flow for the year ending March 31, 2022 was USD 27.32 M, a 19.94% change year over year.
  • Concord Biotech Limited Operating Cash Flow for the year ending March 31, 2021 was USD 22.78 M.
  • Concord Biotech Limited Operating Cash Flow for the year ending March 31, 2020 was USD 20.55 M.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities